Form 4 for SILO Silo Pharma, Inc.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-20 · accession 0001213900-24-101610 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-22 | 2024-11-20+ | SILO | Weisblum Eric | CEO, Pres, Dir | P - Purchase | $0.925 | +5,000 | 182.9K | +3% | +$4,625 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-22 | P | A | 2,500 | $0.9 | 185,432 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-20 | P | A | 2,500 | $0.95 | 182,932 | D | — | — |